Purchases and Sales Made in Q4 2019 in Syros Pharmaceuticals, Inc. (SYRS)
This table provides information about the institutional ownership of Syros Pharmaceuticals, Inc. (SYRS) during Q4 2019. The information is specifically focused on institutions that hold shares of Syros Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 21, 2020
Q4 2019
|
Candriam S.C.A.
|
SELL
|
- |
-169KClosed |
$764K - $1.71M
|
0
$0
|
|
|
Feb 14, 2020
Q4 2019
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-285K- 29.2% |
$1.29M - $2.88M
|
690K
$1.47M
|
|
|
Feb 14, 2020
Q4 2019
|
683 Capital Management, LLC
New York, NY |
SELL
|
- |
-430KClosed |
$1.94M - $4.34M
|
0
$0
|
|
|
Feb 05, 2020
Q4 2019
|
Arch Venture Management, LLC
Chicago, IL |
SELL
|
- |
-541K- 14.04% |
$2.45M - $5.47M
|
3.31M
$7.06M
|
|
|
Feb 14, 2020
Q4 2019
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-3.68M- 94.54% |
$16.6M - $37.1M
|
212K
$452K
|